![]() Promethera Biosciences Promethera Biosciences is a healthcare company developing cell therapy technologies for chronic liver diseases. | ![]() Poxel Poxelis a research integrated pharmaceutical company that develops products for metabolic diseases. | ![]() Gilead Sciences Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines. | |
Founding Date | Founding Date 2009 | Founding Date 2009 | Founding Date 1987 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Mont-Saint-Guibert, BE HQ Charleroi, BE Ganshoren, BE Chuo City, JP Chuo City, JP Basel, CH Durham, US see more | Locations Lyon, FR HQ Chiyoda City, JP Cambridge, US | Locations Foster City, US HQ Buenos Aires, AR Melbourne, AU Wien, AT Machelen, BE São Paulo, BR Edmonton, CA see more |
Employees | Employees 185% decrease | Employees 6 | Employees 18,0006% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 18.3 m | Valuation ($) 110.5 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €6.6m (FY, 2024) | Revenue (est.) $29.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €2.8m (FY, 2024) | Cost of goods $6.2b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit €3.8m (FY, 2024) | Gross profit $23.2b (FY, 2025) |
Net income | Net income N/A | Net income (€18.3m) (FY, 2024) | Net income $8.5b (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 146m | Total funding raised $ 33.8m | Total funding raised N/A |

Poxelis a research integrated pharmaceutical company that develops products for metabolic diseases.
View company
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.
View company